These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31000698)

  • 21. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
    Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
    Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia.
    Nogami A; Oshikawa G; Okada K; Fukutake S; Umezawa Y; Nagao T; Kurosu T; Miura O
    Oncotarget; 2015 Apr; 6(11):9189-205. PubMed ID: 25826077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chromatin-remodeling factor
    Heshmati Y; Türköz G; Harisankar A; Kharazi S; Boström J; Dolatabadi EK; Krstic A; Chang D; Månsson R; Altun M; Qian H; Walfridsson J
    Haematologica; 2018 Jul; 103(7):1169-1181. PubMed ID: 29599201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.
    Nishioka C; Ikezoe T; Yang J; Yokoyama A
    PLoS One; 2015; 10(5):e0125017. PubMed ID: 25955299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells.
    Lee MC; Kuo YY; Chou WC; Hou HA; Hsiao M; Tien HF
    J Leukoc Biol; 2014 Jan; 95(1):105-15. PubMed ID: 24018353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming.
    Sevinç K; Sevinç GG; Cavga AD; Philpott M; Kelekçi S; Can H; Cribbs AP; Yıldız AB; Yılmaz A; Ayar ES; Arabacı DH; Dunford JE; Ata D; Sigua LH; Qi J; Oppermann U; Onder TT
    Stem Cell Reports; 2022 Dec; 17(12):2629-2642. PubMed ID: 36332631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency.
    Cao Z; Budinich KA; Huang H; Ren D; Lu B; Zhang Z; Chen Q; Zhou Y; Huang YH; Alikarami F; Kingsley MC; Lenard AK; Wakabayashi A; Khandros E; Bailis W; Qi J; Carroll MP; Blobel GA; Faryabi RB; Bernt KM; Berger SL; Shi J
    Mol Cell; 2021 Sep; 81(17):3604-3622.e10. PubMed ID: 34358447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia.
    Shahjahani M; Abroun A; Saki N; Bagher Mohammadi SM; Rezaeeyan H
    Lab Med; 2020 Jul; 51(4):345-351. PubMed ID: 31860086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
    Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
    Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation.
    Garg S; Ni W; Chowdhury B; Weisberg EL; Sattler M; Griffin JD
    Cell Death Differ; 2024 Jul; 31(7):868-880. PubMed ID: 38816579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
    Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
    Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M
    Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transcription factor STAT5 catalyzes Mannich ligation reactions yielding inhibitors of leukemic cell proliferation.
    Wong EL; Nawrotzky E; Arkona C; Kim BG; Beligny S; Wang X; Wagner S; Lisurek M; Carstanjen D; Rademann J
    Nat Commun; 2019 Jan; 10(1):66. PubMed ID: 30622248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells.
    Secchiero P; Zerbinati C; di Iasio MG; Melloni E; Tiribelli M; Grill V; Zauli G
    Curr Drug Metab; 2007 May; 8(4):395-403. PubMed ID: 17504227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
    Spiekermann K; Bagrintseva K; Schwab R; Schmieja K; Hiddemann W
    Clin Cancer Res; 2003 Jun; 9(6):2140-50. PubMed ID: 12796379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
    Folkerts H; Hilgendorf S; Wierenga ATJ; Jaques J; Mulder AB; Coffer PJ; Schuringa JJ; Vellenga E
    Cell Death Dis; 2017 Jul; 8(7):e2927. PubMed ID: 28703806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression.
    Li J; Tang B; Miao Y; Li G; Sun Z
    Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37830151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.